208 related articles for article (PubMed ID: 29396074)
1. Direct oral anticoagulant and antiplatelet combination therapy: Hemorrhagic events in coronary artery stent recipients.
Bekelis K; Chang CH; Malenka D; Morden NE
J Clin Neurosci; 2018 Apr; 50():24-29. PubMed ID: 29396074
[TBL] [Abstract][Full Text] [Related]
2. Direct Oral Anticoagulants Would Be Best Choice for Atrial Fibrillation Patients After Coronary Stenting: Retrospective Study in a Japanese Population.
Koiwaya H; Watanabe N; Kuriyama N; Shibata Y
Kurume Med J; 2023 Jul; 68(2):97-106. PubMed ID: 37100602
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and major bleeding outcomes with antiplatelet and direct oral anticoagulants in patients with acute coronary syndrome and atrial fibrillation: A population-based analysis.
Dawwas GK; Barnes GD; Dietrich E; Cuker A; Leonard CE; Genuardi MV; Lewis JD
Am Heart J; 2021 Dec; 242():71-81. PubMed ID: 34450051
[TBL] [Abstract][Full Text] [Related]
4. Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation.
Douros A; Renoux C; Yin H; Filion KB; Suissa S; Azoulay L
Am J Med; 2019 Feb; 132(2):191-199.e12. PubMed ID: 30691551
[TBL] [Abstract][Full Text] [Related]
5. Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease.
Sindet-Pedersen C; Lamberts M; Staerk L; Nissen Bonde A; Berger JS; Pallisgaard JL; Lock Hansen M; Torp-Pedersen C; Gislason GH; Olesen JB
J Am Coll Cardiol; 2018 Oct; 72(15):1790-1800. PubMed ID: 30286922
[TBL] [Abstract][Full Text] [Related]
6. Comparative Outcomes Between Direct Oral Anticoagulants, Warfarin, and Antiplatelet Monotherapy Among Chinese Patients with Atrial Fibrillation: A Population-Based Cohort Study.
Li X; Pathadka S; Man KKC; Ng VWS; Siu CW; Wong ICK; Chan EW; Lau WCY
Drug Saf; 2020 Oct; 43(10):1023-1033. PubMed ID: 32557348
[TBL] [Abstract][Full Text] [Related]
7. Effect of Procedure and Coronary Lesion Characteristics on Clinical Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights From the PIONEER AF-PCI Trial.
Kerneis M; Gibson CM; Chi G; Mehran R; AlKhalfan F; Talib U; Pahlavani S; Mir M; Bode C; Halperin JL; Nafee T; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Fox KAA; Cohen M
JACC Cardiovasc Interv; 2018 Apr; 11(7):626-634. PubMed ID: 29550085
[TBL] [Abstract][Full Text] [Related]
8. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
[TBL] [Abstract][Full Text] [Related]
9. Direct oral anticoagulant plus antiplatelet therapy: prescribing practices and bleeding outcomes.
Tinkham TT; Vazquez SR; Jones AE; Witt DM
J Thromb Thrombolysis; 2020 Apr; 49(3):492-496. PubMed ID: 31776847
[TBL] [Abstract][Full Text] [Related]
10. Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation: Insights From the PIONEER AF-PCI Trial.
Kerneis M; Yee MK; Mehran R; Nafee T; Bode C; Halperin JL; Peterson ED; Verheugt FWA; Wildgoose P; van Eickels M; Lip GYH; Cohen M; Fox KAA; Gibson CM
Circ Cardiovasc Interv; 2019 Nov; 12(11):e008160. PubMed ID: 31707805
[TBL] [Abstract][Full Text] [Related]
11. Comparison of real-world outcomes in patients with nonvalvular atrial fibrillation treated with direct oral anticoagulant agents or warfarin.
Datar M; Crivera C; Rozjabek H; Abbass IM; Xu Y; Pasquale MK; Schein JR; Andrews GA
Am J Health Syst Pharm; 2019 Feb; 76(5):275-285. PubMed ID: 30698654
[TBL] [Abstract][Full Text] [Related]
12. Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients.
Shireman TI; Howard PA; Kresowik TF; Ellerbeck EF
Stroke; 2004 Oct; 35(10):2362-7. PubMed ID: 15331796
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of endovascular venous stenting in patients on direct oral anticoagulants and antiplatelet therapy at a tertiary referral center.
Hays K; Jolly M; Silver M; Phillips J; Huff C; Secic M; Ansel G; Kolluri R
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):753-759.e1. PubMed ID: 32827732
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Triple Therapy and Dual Therapy With Direct Oral Anticoagulants Compared to Warfarin.
Amano H; Saito D; Yabe T; Okubo R; Toda M; Ikeda T
Int Heart J; 2017 Aug; 58(4):570-576. PubMed ID: 28701676
[TBL] [Abstract][Full Text] [Related]
15. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
16. Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation.
Hess CN; Peterson ED; Peng SA; de Lemos JA; Fosbol EL; Thomas L; Bhatt DL; Saucedo JF; Wang TY
J Am Coll Cardiol; 2015 Aug; 66(6):616-27. PubMed ID: 26248987
[TBL] [Abstract][Full Text] [Related]
17. Equivalent inpatient mortality among direct-acting oral anticoagulant and warfarin users presenting with major hemorrhage.
Bialkowski W; Tan S; Mast AE; Kiss JE; Kor D; Gottschall J; Wu Y; Roubinian N; Triulzi D; Kleinman S; Choi Y; Brambilla D; Zimrin A;
Thromb Res; 2020 Jan; 185():109-118. PubMed ID: 31794885
[TBL] [Abstract][Full Text] [Related]
18. Major bleeding complications related to combined antithrombotic therapy in atrial fibrillation patients 12 months after coronary artery stenting.
Kawai H; Watanabe E; Yamamoto M; Harigaya H; Sano K; Takatsu H; Muramatsu T; Naruse H; Sobue Y; Motoyama S; Sarai M; Takahashi H; Arakawa T; Kan S; Sugiura A; Murohara T; Ozaki Y
J Cardiol; 2015 Mar; 65(3):197-202. PubMed ID: 25266323
[TBL] [Abstract][Full Text] [Related]
19. Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions.
Faza NN; Mentias A; Parashar A; Chaudhury P; Barakat AF; Agarwal S; Wayangankar S; Ellis SG; Murat Tuzcu E; Kapadia SR
Catheter Cardiovasc Interv; 2017 Feb; 89(2):E64-E74. PubMed ID: 27220088
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of intraocular hemorrhages under monotherapy or combination therapy of antiplatelets and anticoagulants using the Japanese Adverse Drug Event Report database.
Tanaka J; Koseki T; Sekido K; Kimata M; Ito Y; Yamada S
J Pharm Pharm Sci; 2023; 26():11263. PubMed ID: 37122387
[No Abstract] [Full Text] [Related]
[Next] [New Search]
